• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Plenary debate of randomized phase III trial of neoadjuvant MVAC plus cystectomy versus cystectomy alone in patients with locally advanced bladder cancer.

作者信息

Bajorin D F

机构信息

Genitourinary and Head and Neck Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

出版信息

J Clin Oncol. 2001 Sep 15;19(18 Suppl):17S-20S.

PMID:11560966
Abstract
摘要

相似文献

1
Plenary debate of randomized phase III trial of neoadjuvant MVAC plus cystectomy versus cystectomy alone in patients with locally advanced bladder cancer.局部晚期膀胱癌患者新辅助MVAC加膀胱切除术与单纯膀胱切除术的随机III期试验全体辩论
J Clin Oncol. 2001 Sep 15;19(18 Suppl):17S-20S.
2
Neoadjuvant chemotherapy is not (yet) standard treatment for muscle-invasive bladder cancer.新辅助化疗尚未成为肌层浸润性膀胱癌的标准治疗方法。
J Clin Oncol. 2001 Sep 15;19(18 Suppl):21S-26S.
3
[Neoadjuvant chemotherapy for invasive bladder cancer].[浸润性膀胱癌的新辅助化疗]
Gan To Kagaku Ryoho. 2001 Nov;28(12):1838-44.
4
The current status of perioperative chemotherapy for invasive bladder cancer: a multiinstitutional retrospective study in Japan.浸润性膀胱癌围手术期化疗的现状：日本一项多机构回顾性研究
Int J Clin Oncol. 2005 Apr;10(2):133-8. doi: 10.1007/s10147-004-0474-5.
5
Adjuvant chemotherapy for deep muscle-invasive transitional cell bladder carcinoma - a practice guideline.肌层浸润性移行细胞膀胱癌的辅助化疗——实践指南
Can J Urol. 2002 Oct;9(5):1625-33.
6
Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer.一项针对局部晚期膀胱癌根治性膀胱切除术后辅助化疗与对照组进行对比试验的完整长期生存数据。
BJU Int. 2006 Jan;97(1):42-7. doi: 10.1111/j.1464-410X.2006.05859.x.
7
Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.接受保守多模式治疗的局部晚期膀胱癌患者的临床结局
Urology. 2004 Sep;64(3):488-93. doi: 10.1016/j.urology.2004.04.088.
8
Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer.一项关于局部晚期膀胱癌根治性膀胱切除术后辅助化疗与对照组对比试验的完整长期生存数据。
BJU Int. 2006 Jun;97(6):1348; author reply 1348-50. doi: 10.1111/j.1464-410X.2006.06279_3.x.
9
Neoadjuvant treatment for invasive bladder cancer: is it worthwhile?浸润性膀胱癌的新辅助治疗：是否值得？
Acta Urol Belg. 1996 May;64(2):39-42.
10
[Neoadjuvant chemotherapy in muscle-invasive bladder cancer].[肌肉浸润性膀胱癌的新辅助化疗]
Gan To Kagaku Ryoho. 2007 Nov;34(11):1745-9.

引用本文的文献

1
Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-Analysis.肌肉浸润性膀胱癌的新辅助化疗：系统评价和两步荟萃分析
Oncologist. 2016 Jun;21(6):708-15. doi: 10.1634/theoncologist.2015-0440. Epub 2016 Apr 6.
2
A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer: final results.一项局部晚期尿路上皮癌患者中先后接受异环磷酰胺、多柔比星和吉西他滨新辅助化疗及顺铂、吉西他滨和异环磷酰胺序贯治疗的 2 期临床试验：最终结果。
Cancer. 2013 Feb 1;119(3):540-7. doi: 10.1002/cncr.27751. Epub 2012 Aug 22.
3
New imaging modalities in bladder cancer.
膀胱癌的新型成像方式
World J Urol. 2006 Nov;24(5):473-80. doi: 10.1007/s00345-006-0118-7.
4
FDG-PET for preoperative staging of bladder cancer.用于膀胱癌术前分期的氟代脱氧葡萄糖正电子发射断层扫描（FDG-PET）
Eur J Nucl Med Mol Imaging. 2005 Dec;32(12):1412-7. doi: 10.1007/s00259-005-1886-9. Epub 2005 Aug 31.
5
Neoadjuvant chemotherapy for invasive bladder cancer.浸润性膀胱癌的新辅助化疗
Cochrane Database Syst Rev. 2005 Apr 18;2004(2):CD005246. doi: 10.1002/14651858.CD005246.
6
Selective bladder preservation for muscle-invasive transitional cell carcinoma of the urinary bladder.膀胱肌层浸润性移行细胞癌的选择性膀胱保留术
Br J Cancer. 2004 Feb 9;90(3):578-81. doi: 10.1038/sj.bjc.6601580.